A Phase 1 Study to Evaluate AMP-514

This study is currently recruiting participants.
Verified December 2013 by Amplimmune
Sponsor:
Collaborator:
MedImmune LLC
Information provided by (Responsible Party):
Amplimmune
ClinicalTrials.gov Identifier:
NCT02013804
First received: December 12, 2013
Last updated: December 18, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)